The U.S. Navy awarded contracts worth up to $6 million to Entegrion, a small Research Triangle Park biotechnology company developing blood-related products to help treat serious injuries.
The contracts will help develop products that can be used for combat injuries such as Stasix, designed to help control internal bleeding.
Entegrion was founded in 2002 based on blood research at UNC-Chapel Hill.
Assistant Business Editor Alan M. Wolf joined the N&O in 1999 covering the business of health care. He became an editor in 2001, and helps oversee the paper's daily business coverage and Sunday Work&Money section. He lives in Clayton with his wife and two children. Reach him at 919-829-4572 or 
